Maverick Capital’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-564,329
Closed -$19.2M 437
2022
Q3
$19.2M Hold
564,329
0.43% 41
2022
Q2
$16.4M Hold
564,329
0.41% 40
2022
Q1
$15.1M Sell
564,329
-40,579
-7% -$958K 0.27% 57
2021
Q4
$15.6M Buy
604,908
+104,908
+21% +$2.62M 0.18% 66
2021
Q3
$11.8M Hold
500,000
0.12% 73
2021
Q2
$22.2M Buy
+500,000
New +$18.4M 0.21% 61

Other funds holding PRVA

Maverick Capital's PRVA Position: Q4 2022 in Review

Maverick Capital sold out of Privia Health (PRVA) in Q4 2022, closing a stake of 564,329 shares — an estimated $19.2M sold.

Maverick Capital first reported a position in PRVA in Q2 2021 and held it in 6 quarters. The position peaked at $22.2M in Q2 2021. 192 funds tracked by Wall St. Rank hold PRVA as of Q4 2022.

  • Maverick Capital reported no remaining Privia Health position as of Q4 2022 after selling out during the quarter.
  • Maverick Capital sold 564,329 Privia Health shares in Q4 2022, an estimated $19.2M.
  • Maverick Capital first reported a position in Privia Health in Q2 2021 and held it in 6 quarters.
  • Maverick Capital's Privia Health position peaked at $22.2M in Q2 2021.
  • 192 funds tracked by Wall St. Rank held Privia Health as of Q4 2022.

Based on Maverick Capital's 13F filing for Q4 2022, filed 14 Feb 2023.